Another report demonstrated that miR-182 suppressed cell proliferation of lung cancer cell line A549 in vitro and tumor growth in vivo through its interference with the target gene cortactin (CTTN) by epigenetic modification [36]. This evidence concerns the gene CTTN and lung carcinoma.